Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Net Margin (2019 - 2020)

Updated

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Net Margin (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 0.83%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 24.24%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 28.01%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 20.69%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 37.28%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 29.27%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 19.55%
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 -9,163.34%
Aug 31, 2020 -5,216.66%
May 31, 2020 -142.68%
Nov 30, 2019 42.26%
Aug 31, 2019 171.63%
May 31, 2019 -7.03%
API Access

Reviva Pharmaceuticals Holdings Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=RVPH&period=max&api_key=YOUR_API_KEY